Search research articles
Contact Us
Filters
Showing results (1-10 of 501) with videos related to
Page
of 51
Sort By:
Journal of Biological Methods
|
December 19, 2025
From epidemiology to precision prevention: Why the latest breast cancer roadmap deserves your attention
Ralf Weiskirchen
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 22, 2017
Therapeutic targeting of the mitochondrial reactive oxygen species engine prevents portal hypertension and hepatic fibrogenesis
Ralf Weiskirchen
Current Medical Research and Opinion
|
May 25, 2017
Fast progression of liver damage in lysosomal acid lipase deficiency
Ralf Weiskirchen
Frontiers in Pharmacology
|
January 19, 2016
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
Ralf Weiskirchen
Hepatology (Baltimore, Md.)
|
August 30, 2022
Letter to the Editor: LO2, a misidentified cell line: Some data should be interpreted with caution
Ralf Weiskirchen
Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology
|
March 18, 2022
The Beatles in life sciences: Facts and fictions
Ralf Weiskirchen
International Journal of Cancer
|
May 10, 2026
ICLAC Register Version 14: A Continuing Legacy of the International Journal of Cancer
Ralf Weiskirchen
Journal of Ethnopharmacology
|
February 23, 2025
Critical comment on "Inhibitory effects of Raddeanin A on hepatocellular carcinoma cells"
Ralf Weiskirchen
Signal Transduction and Targeted Therapy
|
September 10, 2023
Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
Ralf Weiskirchen
Journal of Cellular Biochemistry
|
October 14, 2022
Novel therapeutic targets in liver pathology: From basic science to clinical translation
Ralf Weiskirchen
Page
of 51
Search research articles
Search
Showing results (1-10 of 501) with videos related to
Sort By:
Page
of 51
Journal of Biological Methods
|
December 19, 2025
From epidemiology to precision prevention: Why the latest breast cancer roadmap deserves your attention
Ralf Weiskirchen
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 22, 2017
Therapeutic targeting of the mitochondrial reactive oxygen species engine prevents portal hypertension and hepatic fibrogenesis
Ralf Weiskirchen
Current Medical Research and Opinion
|
May 25, 2017
Fast progression of liver damage in lysosomal acid lipase deficiency
Ralf Weiskirchen
Frontiers in Pharmacology
|
January 19, 2016
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
Ralf Weiskirchen
Hepatology (Baltimore, Md.)
|
August 30, 2022
Letter to the Editor: LO2, a misidentified cell line: Some data should be interpreted with caution
Ralf Weiskirchen
Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology
|
March 18, 2022
The Beatles in life sciences: Facts and fictions
Ralf Weiskirchen
International Journal of Cancer
|
May 10, 2026
ICLAC Register Version 14: A Continuing Legacy of the International Journal of Cancer
Ralf Weiskirchen
Journal of Ethnopharmacology
|
February 23, 2025
Critical comment on "Inhibitory effects of Raddeanin A on hepatocellular carcinoma cells"
Ralf Weiskirchen
Signal Transduction and Targeted Therapy
|
September 10, 2023
Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
Ralf Weiskirchen
Journal of Cellular Biochemistry
|
October 14, 2022
Novel therapeutic targets in liver pathology: From basic science to clinical translation
Ralf Weiskirchen
Page
of 51